Actinium Pharmaceuticals, Inc. (ATNM) Operating margin 2021–2025
Actinium Pharmaceuticals, Inc. (ATNM) operating margin by fiscal year — reported operating income divided by reported revenue.
-40274.4%FY2025 · since FY2021: -2182.2% → -40274.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -40274.4% | — |
| FY2023 | -64098.8% | -60787.7 pp |
| FY2022 | -3311.1% | -1128.9 pp |
| FY2021 | -2182.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ATNM financial trends
ATNM RevenueATNM Net incomeATNM Net marginATNM Gross profitATNM Gross marginATNM Operating incomeATNM Operating cash flowATNM Free cash flowATNM Capital expendituresATNM Return on equityATNM Stock buybacksATNM Dividends paidATNM Total assetsATNM Total liabilitiesATNM Shareholders’ equityATNM overview →